Skip to main content
Journal of Veterinary Science logoLink to Journal of Veterinary Science
. 2014 Sep 16;15(3):423–426. doi: 10.4142/jvs.2014.15.3.423

A reverse transcription loop-mediated isothermal amplification assay to rapidly diagnose foot-and-mouth disease virus C

Yao-zhong Ding 1,2, Jian-hua Zhou 1, Li-na Ma 1, Yan-ni Qi 1, Gang Wei 3, Jie Zhang 1,2,, Yong-guang Zhang 1,2,
PMCID: PMC4178144  PMID: 24690607

Abstract

A reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay was developed to rapidly detect foot-and-mouth disease virus serotype C (FMDV C). By testing 10-fold serial dilutions of FMDV C samples, sensitivity of the FMDV C RT-LAMP was found to be 10 times higher than that of conventional reverse transcription-PCR (RT-PCR). No cross-reactivity with A, Asia 1, or O FMDV or swine vesicular disease virus (SVDV) indicated that FMDV C RT-LAMP may be an exciting novel method for detecting FMDV C.

Keywords: foot-and-mouth disease; foot-and-mouth disease virus serotype C; reverse transcription loop-mediated isothermal amplification; reverse transcription-PCR, sensitivity

Introduction

Foot-and-mouth disease virus (FMDV) is a member of the genus Aphthovirus of the family Picornaviridae, and includes seven different serotypes [2]. FMDV serotypes O and A are widely distributed worldwide. In contrast, FMDV serotypes SAT 1, SAT 2, and SAT 3 are normally restricted to Africa while FMDV serotype Asia 1 is limited to Asia [4,6]. Historically, FMDV serotype C (FMDV C) has had a narrow geographic distribution compared to both type O and type A. This virus had not been identified in Southeast Asia until it was introduced into the Philippines in 1976 [7]. No more case was confirmed after Kenya in 2005 and the Amazon region of Brazil in 2004 [5,10]. It has been assumed that FMDV C is disappearing from Africa [9]. However, an investigation by Tekleghiorghis et al. [11] and similar research in Uganda [1] indicated that FMDV C may still exist in Eritrea. These findings suggest that FMDV C might be circulating without being detected.

Generally, virus isolation is considered to be the "gold standard" for diagnosing diseases. Other assays including antigen detection by enzyme-linked immunosorbent assay (ELISA), conventional reverse transcription-PCR (RT-PCR), and real-time RT-PCR are recommended as primary diagnostic techniques by the Office International Des Epizooties or World Organization for Animal Health (OIE) World Reference Laboratory (WRL). All of these current methods are relatively time-consuming and laborious. To overcome these problems, a rapid, simple, and practical assay called reverse transcription loop-mediated isothermal amplification (RT-LAMP) was first reported by Notomi et al. [8]. However, the capability of RT-LAMP to detect FMDV C RNA has not been evaluated. This is of particular interest because the ability to make a simple, rapid preclinical diagnosis would be extremely useful for controlling FMDV. In the current study, we compared the sensitivity and specificity of the RT-LAMP assay for detecting FMDV C in clinical samples to that of conventional RT-PCR.

Materials and Methods

Viral strains and samples

Clinical samples of FMDV O/CHA/1999, A/CHA/2009, and Asia 1/CHA/2005 as well as swine vesicular disease virus (SVDV) were provided from the OIE and China National Foot-and-Mouth Disease Reference Laboratory. FMDV C that was introduced from a laboratory in the former Union of Soviet Socialist Republics (USSR) was incubated on Baby Hamster Syrian Kindey Cell (BHK-21), which is a subclone (clone 13) of the parental line established from the kidneys of five unsexed mice, provided by the OIE and China National Foot-and-Mouth Disease Reference Laboratory. Identities of all viruses in the 41 samples (Table 1) were confirmed by RT-PCR, and the procedure is as follows, 50℃ for 30 min, 95℃ for 8 min, 35 cycles of 94℃ for 1 min, 58℃ for 1 min and 72℃ for 1 min, extension at 72℃ for 10 min.

Table 1.

Results of the reverse transcription loop-mediated isothermal amplification (RT-LAMP) analysis of 41 clinical samples

graphic file with name jvs-15-423-i001.jpg

+, positive reaction; -, negative control. FMDV: foot-and-mouth disease virus, SVDV: swine vesicular disease virus.

RNA extraction

RNA was extracted from the positive samples which are FMDV O/CHA/1999, A/CHA/2009, and Asia 1/CHA/2005 as well as SVDV provided by China National Foot-and-Mouth Disease Reference Laboratory and blood of healthy pig which was negatively detected by RT-PCR or ELISA for FMDV assay, with a TaKaRa MiniBEST Viral RNA/DNA Extraction Kit (ver. 4.0; Takara Bio, Japan) according to the manufacturer's instructions. After extraction, the RNA was eluted in 30 µL of elution buffer and stored at -70℃ until further use.

Conventional RT-PCR and RT-LAMP

The detection of FMDV by RT-PCR was performed with previously described primers [3]. A conserved sequence in the VP1 region of FMDV C genome was selected as the target sequence for RT-PCR (Table 1) for VP1 can discriminate FMDV C from FMDV O, A and Asia 1 as well as other viruses, such as SVDV. RT-PCR was performed in a 25-µL reaction containing PrimeScript 1 step Enzyme Mix 1 µL (Takara Bio), 2×1 step buffer (Takara Bio) 12.5 µL , RNase Free dH2O (Takara Bio) 8.9 µL, 0.8 µL of each upstream and downstream primer, template RNA 1 µL.

A set of four RT-LAMP primers including two outer primers and two inner primers that recognize six distinct regions in the conserved target sequence of all topotypes of the virus were designed based on FMDV C genome sequence alignment in National Center for Biotechnology Information (GenBank Accession No. M90368.1; Table 2). RT-LAMP was carried out in a conventional water bath (Beijing Changan Scientific instrument, China) in a 25-µL reaction containing 2.0 µM each of FIP and BIP primer, 0.2 µM each of F and B primer, 1.0 mM of each deoxyribonucleoside triphosphate (dNTP), 8 U of Bst DNA polymerase (New England Biolabs, USA), and 1 U of THERMO-X reverse transcriptase (Invitrogen, USA), 2.5-µL 10× buffer (containing 4 mM of MgSO4 and 0.8 M betaine), and 1 µL of extracted template RNA in a 0.2-mL Eppendorf tube (Axygen Scientific, USA). Amplification was performed at 60℃ for 45 min and then terminated by A; Lane 3, FMDV Asia 1; Lane 4, FMDV O; and Lane 5, SVDV. heating the reactions at 80℃ for 10 min. The RT-LAMP and RT-PCR products were separated by 2.5% agarose gel electrophoresis for analysis.

Table 2.

Results of the reverse transcription loop-mediated isothermal amplification (RT-LAMP) analysis of 41 clinical samples

graphic file with name jvs-15-423-i002.jpg

Measurement of RT-LAMP sensitivity and specificity

To compare the detection limits of RT-LAMP and RT-PCR, 10-fold serial dilutions of all samples [3.25 × 105 ng/mL to 3.25 × 10-1 ng/mL, measured by DU Series 700 (Beckman Coulter, Germany)] were prepared to analyze the sensitivities of the two techniques. To assess the specificity of RT-LAMP, 41 clinical samples including 4 FMDV C, 10 FMDV A, 12 FMDV Asia 1, 10 FMDV O, 4 PRRSV, and one negative control (Table 1) were analyzed.

Results

Comparison of RT-LAMP and RT-PCR sensitivity

A positive RT-LAMP result was associated with the appearance of many bands of different sizes viewed by agarose electrophoresis. Amplification by RT-LAMP produced different bands with a ladder-like pattern (Fig. 1). To compare the sensitivity and detection limits of RT-LAMP and RT-PCR, we used both techniques to evaluate the same FMDV C samples. As shown in Fig. 1, the detection limit of RT-PCR was 3.25 × 100 ng/mL. In contrast, the detection limit of RT-LAMP was about 3.25 × 10-1 ng/mL which was 10 times higher than the limit of conventional RT-PCR.

Fig. 1.

Fig. 1

Comparing the sensitivity of RT-LAMP and RT-PCR for the detection of C-type FMDV using agarose gel electrophoresis. (A) Lane M1, DNA marker DL-100 (1500, 1000, 900, 800, 700, 600, 500, 400, 300, 200 and 100 bp; Takara Bio,Japan). Lanes 1~7, different dilutions (3.25 × 105 ng/mL to 3.25 × 10-1 ng/mL) of FMDV C subjected to the RT-LAMP assay. (B) Lane M2, DNA marker DL-2000 (2000, 1000, 750, 500, 250 and 100 bp; Takara Bio). Lanes 1~5, different dilutions (3.25 × 104 ng/mL to 3.25 × 100 ng/mL) of FMDV C subjected to RT-PCR. RT-PCR products corresponded to specific amplification of the FMDV C VP1 gene with a detection limit of 3.25 × 100 ng/mL. In contrast, the detection limit for RT-LAMP was 3.25 × 10-1 ng/mL.

Evaluation of FMDV RT-LAMP specificity

Agarose gel electrophoresis analysis indicated that only FMDV C RNA produced a specific positive reaction with RT-LAMP. No cross-reactivity was observed with the SVDV, FMDV O, FMDV A, or FMDV Asia 1 samples. The healthy tissues produced a negative reaction (Fig. 2).

Fig. 2.

Fig. 2

Analysis of RT-LAMP specificity for FMDV C. The ability of the assay to distinguish FMDV C from FMDV A, O, and Asia 1 as well as SVDV was evaluated. Lane M, DNA marker DL-100 (1500, 1000, 900, 800, 700, 600, 500, 400, 300, 200 and 100 bp; Takara Bio); Lane 1, FMDV C; Lane 2, FMDV A; Lane 3, FMDV Asia 1; Lane 4, FMDV O; and Lane 5, SVDV.

Discussion

FMDV is an important veterinary pathogen that can cause widespread epidemics. Early detection of FMD is essential for effective disease control. Simple, rapid, and noninvasive diagnostic tests are critical for FMD diagnosis.

Previous studies [1,11] indicated that FMDV C may circulate without being detected. Therefore, the development of a highly sensitive assay for detecting FMDV C is critical for preventing and controlling FMDV C epidemics. The four samples containing FMDV C were identified as positive while the one negative control and 36 samples containing other viruses were identified as negative (Table 1). The assay can be completed within 1 h. Due to its rapidity, sensitivity, and specificity, the RT-LAMP assay is suitable for making clinical diagnoses and FMDV C surveillance. Results from this study indicated that RT-LAMP was 10 times more sensitive than traditional RT-PCR. The detection limit of RT-LAMP demonstrated that this assay would increase the likelihood of recognizing FMDV C in animals or animal products. Furthermore, RT-LAMP might be developed for confirming virus serotypes.

Acknowledgments

Clinical samples were provided by the OIE, National Foot and Mouth Disease Reference Laboratory of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS), China. This work was supported in part by grants from the International Science and Technology Cooperation Program of China (No. 2012DFG31890) and Gansu Provincial Funds for Distinguished Young Scientists (1111RJDA005). This study was also supported by the National Natural Science Foundation of China (No. 30700597 and 31072143).

Footnotes

There is no conflict of interest.

References

  • 1.Ayebazibwe C, Mwiine FN, Balinda SN, Tjørnehøj K, Masembe C, Muwanika VB, Okurut ARA, Siegismund HR, Alexandersen S. Antibodies against foot-and-mouth disease (FMD) virus in African buffalos (Syncerus caffer) in selected National Parks in Uganda (2001-2003) Transbound Emerg Dis. 2010;57:286–292. doi: 10.1111/j.1865-1682.2010.01147.x. [DOI] [PubMed] [Google Scholar]
  • 2.Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL. Comparative genomics of foot-and-mouth disease virus. J Virol. 2005;79:6487–6504. doi: 10.1128/JVI.79.10.6487-6504.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Farag MA, Halima EW, Abeer AT. 1rst Ann Confr FVM Moshtohor. 2004. Detection of FMD Virus using A Dot Immunoblot and RT-PCR from field Samples; pp. 67–77. [Google Scholar]
  • 4.Fernández J, Agüero M, Romero L, Sánchez C, Belák S, Arias M, Sánchez-Vizcaíno JM. Rapid and differential diagnosis of foot-and-mouth disease, swine vesicular disease, and vesicular stomatitis by a new multiplex RT-PCR assay. J Virol Methods. 2008;147:301–311. doi: 10.1016/j.jviromet.2007.09.010. [DOI] [PubMed] [Google Scholar]
  • 5.Food and Agriculture Organization of the United Nations. Foot-and-mouth disease: situation worldwide and major epidemiological events in 2005-2006. FAO EMPRES. 2007;1:1–11. [Google Scholar]
  • 6.Grubman MJ, Baxt B. Foot-and-mouth disease. Clin Microbiol Rev. 2004;17:465–493. doi: 10.1128/CMR.17.2.465-493.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Knowles NJ, Samuel AR. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003;91:65–80. doi: 10.1016/s0168-1702(02)00260-5. [DOI] [PubMed] [Google Scholar]
  • 8.Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28:E63. doi: 10.1093/nar/28.12.e63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Paton DJ, Sumption KJ, Charleston B. Options for control of foot-and-mouth disease: knowledge, capability and policy. Philos Trans R Soc Lond B Biol Sci. 2009;364:2657–2667. doi: 10.1098/rstb.2009.0100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sangula AK, Siegismund HR, Belsham GJ, Balinda SN, Masembe C, Muwanika VB. Low diversity of foot-and-mouth disease serotype C virus in Kenya: evidence for probable vaccine strain re-introductions in the field. Epidemiol Infect. 2011;139:189–196. doi: 10.1017/S0950268810000580. [DOI] [PubMed] [Google Scholar]
  • 11.Tekleghiorghis T, Moormann RJM, Weerdmeester K, Dekker A. Serological Evidence Indicates that Foot-and- Mouth Disease Virus Serotype O, C and SAT1 are most Dominant in Eritrea. Transbound Emerg Dis. 2013 doi: 10.1111/tbed.12065. Epub ahead of print. doi: 10.1111/tbed.12065. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Veterinary Science are provided here courtesy of The Korean Society of Veterinary Science

RESOURCES